BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

New Survey from Biocompare - Ranks Syngene Systems Top for Customer Satisfaction

November 29 2006 Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce a 2006 report available from major life-sciences media company, Biocompare, has named Syngene image analysers as the best products for reproducibility and customer satisfaction.

The 2006 report titled ‘Imaging and Analysis Systems: Understanding End-User Needs’, available from Biocompare ( www.biocompare.com/research ), is based on the responses of over 520 US scientists currently using gel imaging systems. The researchers surveyed were asked about brand preferences; how many gels and blots they currently work with; the stains and dyes they prefer; as well as future purchasing plans. The survey results showed that although Syngene is not the largest supplier of imagers in the US, the researchers polled gave Syngene top marks in customer satisfaction because its systems provide exceptional reproducibility.

A researcher at a major US biotech company agrees with the survey’s results and said: “I am not surprised the scientists asked are happy with the performance of their Syngene systems. After we assessed several imagers from larger suppliers, we decided from the quality of results it generates, the only one we wanted to buy is from Syngene.”

Paula Maia, Syngene’s Vice President of Sales added: “We are delighted by this new report from Biocompare, because it provides independent confirmation that Syngene is setting the industry benchmark for quality and performance. Although we may not yet have the largest share of the US imaging market, reviews like this will help to endorse Syngene’s excellent reputation. Additionally, it ensures researchers world-wide can be confident that if it is exceptional reproducibility and complete satisfaction they are looking for in an image analyser then a Syngene system is the right choice.”

-Ends-

For Further Information Contact:
Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44(0) 1223-727123 Fax +44 (0) 1223-727101
Email: jayne.arthur@syngene.com  Web site: www.syngene.com 

Editor Contact:
Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax + 44(0) 1462-635327 Email: sue6.pearson@ntlworld.com

Note to Editors

About Syngene


Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists worldwide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997 is a division of the Cambridge based Synoptics Group. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs more than 50 people in its UK and subsidiary operation in Frederick, USA.

About Biocompare

Biocompare, headquartered in South San Francisco, California, is a global media company informing and connecting the buyers, users, and sellers of life science products. By combining an in-depth knowledge of life science products and new technologies with the power of the internet, Biocompare offers a dynamic, relevant, and innovative media-based marketplace for life science information.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreements

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road, Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.